amphetamine has been researched along with Developmental Disabilities in 5 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty-five children born to women who all used amphetamine during pregnancy have been followed prospectively since birth 1976-77." | 7.69 | Amphetamine addiction during pregnancy: 10-year follow-up. ( Eriksson, M; Zetterström, R, 1994) |
| "Sixty-five children born to women who all used amphetamine during pregnancy have been followed prospectively since birth 1976-77." | 3.69 | Amphetamine addiction during pregnancy: 10-year follow-up. ( Eriksson, M; Zetterström, R, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mailman, RB | 1 |
| Lewis, MH | 1 |
| Kilts, CD | 1 |
| Eriksson, M | 2 |
| Zetterström, R | 2 |
| Jonsson, B | 1 |
| Steneroth, G | 1 |
| Denhoff, E | 1 |
| Kinsbourne, M | 1 |
1 review available for amphetamine and Developmental Disabilities
| Article | Year |
|---|---|
Animal models related to developmental disorders: theoretical and pharmacological analyses.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Brain; | 1981 |
4 other studies available for amphetamine and Developmental Disabilities
| Article | Year |
|---|---|
Amphetamine addiction during pregnancy: 10-year follow-up.
Topics: Amphetamine; Child; Child Behavior; Child of Impaired Parents; Child, Preschool; Developmental Disab | 1994 |
Amphetamine abuse during pregnancy: environmental factors and outcome after 14-15 years.
Topics: Adolescent; Amphetamine; Child; Child Behavior Disorders; Cohort Studies; Developmental Disabilities | 2000 |
The natural life history of children with minimal brain dysfunction.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Cerebral Palsy; Child; Child Behavior Di | 1973 |
School problems: diagnosis and treatment.
Topics: Agnosia; Amphetamine; Anxiety; Child; Child, Preschool; Cognition Disorders; Developmental Disabilit | 1973 |